You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國藥現代(600420.SH):與西安新通簽署合作框架協議
格隆匯 06-10 18:28

格隆匯6月10日丨國藥現代(600420.SH)公佈,2021年6月10日,公司與西安新通藥物研究股份有限公司(“西安新通”)簽署了《製劑產品委託獨家生產和獨家銷售及提供營銷服務合作框架協議》(“合作框架協議”)。

經過友好協商,西安新通和國藥現代達成共識,將西安新通(包含西安新通所控制的關聯公司)擁有知識產權並作為藥品上市許可持有人的三款製劑產品委託給國藥現代在大中華區(包括中國大陸、香港、澳門、台灣,下同)獨家生產和獨家銷售(或者提供營銷服務)。

該次簽訂合作框架協議,將會為公司引進新的藥品生產銷售品種,符合公司的戰略發展規劃。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account